HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Armando D'Agostino Selected Research

Armando D'Agostino Research Topics

Disease

14Psychotic Disorders (Schizoaffective Disorder)
01/2024 - 10/2015
14Schizophrenia (Dementia Praecox)
05/2023 - 11/2016
9Bipolar Disorder (Manic Depressive Psychosis)
10/2023 - 01/2018
6Mental Disorders (Mental Disorder)
04/2023 - 01/2021
3Feeding and Eating Disorders (Eating Disorder)
01/2024 - 01/2019
2Neurobehavioral Manifestations
03/2024 - 01/2019
2Major Depressive Disorder (Major Depressive Disorders)
03/2024 - 01/2021
2Sleep Wake Disorders
04/2022 - 11/2016
2COVID-19
11/2020 - 01/2020
2Delirium
11/2020 - 01/2020
2Sleep Deprivation
11/2020 - 01/2020
2Treatment-Resistant Schizophrenia
11/2016 - 11/2016
1Drug-Related Side Effects and Adverse Reactions
01/2023
1Postpartum Depression (Post-Natal Depression)
10/2022
1Sleep Initiation and Maintenance Disorders (Insomnia)
04/2022
1Substance-Related Disorders (Drug Abuse)
01/2022
1Headache (Headaches)
01/2022
1Dyskinesias (Dyskinesia)
01/2022
1Tics (Tic)
01/2022
1Tourette Syndrome (Tourette's Syndrome)
01/2022
1REM Sleep Behavior Disorder
01/2022
1Mood Disorders (Mood Disorder)
01/2022
1Dysthymic Disorder
11/2021
1Personality Disorders (Personality Disorder)
12/2020
1Treatment-Resistant Depressive Disorder
01/2020
1Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
04/2016
1Mania (Manias)
10/2015
1Seizures (Absence Seizure)
02/2015
1Parkinson Disease (Parkinson's Disease)
01/2010

Drug/Important Bio-Agent (IBA)

12Antipsychotic Agents (Antipsychotics)IBA
01/2024 - 10/2015
10Polytetrafluoroethylene (Teflon)FDA Link
01/2024 - 01/2017
4Clozapine (Clozaril)FDA LinkGeneric
01/2023 - 02/2015
3Aripiprazole (Abilify)FDA Link
01/2023 - 01/2020
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
03/2024 - 11/2021
2LithiumIBA
11/2022 - 12/2021
2Paliperidone PalmitateFDA Link
01/2022 - 01/2020
2Olanzapine (Zyprexa)FDA Link
11/2021 - 01/2019
2MelatoninIBA
11/2020 - 01/2020
1VortioxetineIBA
03/2024
1Biomarkers (Surrogate Marker)IBA
01/2024
1Silver Sulfadiazine (SSD)FDA LinkGeneric
05/2023
1Indicators and Reagents (Reagents)IBA
04/2022
1Clonazepam (Rivotril)FDA LinkGeneric
01/2022
1Tiapride HydrochlorideIBA
01/2022
1Risperidone (Risperdal Consta)FDA LinkGeneric
11/2021
1Imipramine (Janimine)FDA LinkGeneric
11/2021
1Amitriptyline (Elavil)FDA LinkGeneric
11/2021
1amineptin (amineptine)IBA
11/2021
1Amisulpride (Solian)IBA
11/2021
1Messenger RNA (mRNA)IBA
01/2021
1Polymethyl Methacrylate (Sol)IBA
11/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1KetamineFDA LinkGeneric
01/2020
1Antidepressive Agents (Antidepressants)IBA
01/2020
1Drug CombinationsIBA
10/2019
1Dopamine (Intropin)FDA LinkGeneric
01/2019
1ElementsIBA
01/2017
1Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
04/2016
1asenapineFDA Link
10/2015
1Bupropion (Wellbutrin)FDA LinkGeneric
02/2015
1Cholinergic Agents (Cholinergics)IBA
01/2010

Therapy/Procedure

4Phototherapy (Light Therapy)
10/2022 - 11/2016
3Injections
10/2023 - 01/2021
2Therapeutics
01/2023 - 11/2021
2Length of Stay
12/2020 - 10/2015
2Chronotherapy
11/2020 - 01/2020
1Self Administration (Administration, Self)
01/2024
1Transcranial Magnetic Stimulation
12/2021
1Transcranial Direct Current Stimulation
01/2019
1Patient Readmission
10/2015
1Aftercare (After-Treatment)
01/2010